We describe a new method for separatingalkalinephosphatase(AP)isoenzymes bymeans of "high-performance" liquid chromatography.Isoenzymes are eluted from the column (Mono Q HR 5/5, a strong anion-exchanger) witha stepwise gradient of LiCI. The isoenzymes originating from small intestine,bone, liver,and bilewere identifiedby use of tissue homogenates,pathologicalsera, and heat inactivation.
Materials and Methods

Apparatus.
For the separation we used a Gilson Model 
G.). A flow-through pho-
tometer with 405-nm ifiter (LKB) and a Model 603 integrator (Packard Instrument Co., Downers Grove, IL) were used for automatic measurement. For tissue homogenization we used a Potter-Elvelijem homogenizer (Heidolph, Kehlheim, F.R.G.). Procedures. Serum samples from adult patients with liver diseases (cholestasis and hepatitis, n = 15) or rickets (n = 2), and from healthy control groups of children (n = 10) were stored at 4#{176}C and examined within a month.
Reagents
The normal reference interval for total A? in serum is: children 110-700
and adults 55-175 UIL. For sample preparation, the serum was centrifuged for (5 mm, 8000 x g) and 100 to 400 ,uL of the supernatant fluid was diluted to 1 mL with 20 mmolfL Tris HC1 (pH 8.2) .
Tissue samples. Specimens of small intestine, liver, and vertebral spongiosa were obtained within 24 h post mortem from adult patients, homogenized in the Tris buffer, then frozen at -72 #{176}C and thawed three times. After a 15-mm centrifugation at 8000 x g, possibly interfering lipids were extracted from the supernate with 1,1,2-trichiorotrifluoroethane (Fluka, Buchs, Switzerland).
Specimens of hepatic bile were obtained from patients who were undergoing Ttube drainage of the common bile duct after cholecystecto- of 500 mmol/L is reached, all at a flow rate of 1 mL/min. We collected 10-drop fractions. After this elution, any remaining protein was removed from the column with 1 mL of 1 mol/L NaC1.
Gel properties.
"Mono Q" is a strong anion exchanger based on a beaded hydrophilic resin with an average particle diameter of 10 pm. The charged group on the resin is -CH2-N(CH3)3. The ionic capacity of the gel is 0.28-0.36 mmollmL. At a flow rate of 1.0 mL/min, the column operates at a back pressure of about iO Pa (10 bar).
Precautions. All solvents were degassed, and ifitered through a 0.22-pin filter. All samples also were so filtered. The Pharmacia pre-ifiter was used, to prolong the useful life of the column.
Determination of isoenzyme activity. The substrate was 4-nitrophenyl phosphate, 5 mmoWL, in 0.5 mol/L diethanolamine hydrochloride (pH 9.8) plus 0.5 mmol of MgCl2 per
liter. This allowed a zero-order reaction of isoenzyme activity at 25#{176}C.
Heat inactivation.
The samples were heated for 15 miiiat 56#{176}C, then quickly cooled underrunning water.
Automation.
Rather than measuring A? in effluent fractions, we mixed the column effluent by means of a tee connection with substrate pumped by a second pump at a flow rate of 0.5 mL/min into a 1-rn Teflon capillary (crosssectional area 1 mm2). This allowed an incubation period of 1 miii at 25#{176}C, after which the absorbance was measured in the flow-through cell. Activities of the isoenzymes were calculated by area integration. Figure 1 depicts the influence of the salt gradient on the elution behavior of the isoenzymes in serum. With use of a linear gradient, the elution pattern was a broad doubleshouldered peak, appearing between LiCI concentrations of 88 and 115 mmol/L, and a sharp main peak, eluted at 130 inmol of LiCl per liter. In contrast, by stepwise elution as many as four peaks were resolved; the first peaks are demonstrated to be bone isoenzymes (KI and Kil), the rest liver isoenzymes (LI and LII).
Results
Elution patterns of isoenzymes in patients with rickets with abnormal concentrations of A? activity in their serum (Figure 2) showed that the high activities are ascribable to the second bone isoenzyme.
Increased activities of LI, LII, and of a third isoenzyme, which was eluted between 185 and 230 rnmol of LiC1 per liter, were found in serum of cholestasis patients.
High activities of KI were detectable in the serum of growing children. In sera of healthy adult controls, LI and LII predominated.
Extraction of isoenzymes from tissue homogenates with Tris HC1 (pH 8.2,20 mmol/L) yielded activities sufficient for isoenzyme detection (Figure 3 ). The isoenzyme of smallintestinal origin (1)) was eluted first at an LiCl concentration of 90 mmol/L. This isoenzyme is eluted at the same time as the first isoenzyme of bone when it is present in serum. represented the main fraction, eluted with 120 mmolfL Lid. The principal fraction of bile fluid (G) followed at LiCl concentrations between 185 and 230 mmol/liter. In addition, homogenates from liver and bile fluid both showed up to four isoenzyme peaks (A), all eluting between LII and G. The elution behavior of serum isoenzymes was consistently identical with that of those from homogenates.
The resolved isoenzymes of bone and liver were additionally characterized by their heat sensitivity and susceptibility to inhibition by iphenylalanine ( Table 1) . The bone isoenzymes were the most heat sensitive. The rates of inactivation of the bone and liver isoenzymes by treatment with i1-phenylalanine were nearly identical.
Precision studies.
Ten replicate analyses of the same serum yielded a CV of 9.3% for the collective isoenzyme activities.
The standard deviation for the elution time corresponding to peak maxima was ± two fractions (n = 40).
Discussion
In accordance with our results, Johnson et al. (15) identified two isoenzyines of bone by polyacrylamide electrophoresis. Their separations showed also an overlap of the isoenzyme originating from small intestine and the first bone isoenzyme. They called the first bone isoenzyme "growth A?." Walker and Polard (16) found two isoenzymes of liver. Crofton and Smith (17) used ion-exchange chromatography to separate the biliary isoenzyme.
They named it "high molecular weight alkaline phosphatase."
The isoenzymes that are characterized in the literature are comparable to the isoenzymes of our separation method, except for those we called "fragment isoenzymes." As far as we know, no such A? isoenzymes have been described hitherto. We suggest that they represent catabolites of the various isoenzymes in serum. They also were detectable in the separations of liver homogenate and bile fluid. In accord with this suggestion, Klein (18) concluded that serum A? isoenzymes are catabolized in the liver and in part secreted into bile.
We used LiC1 as the elution salt because it gave a better resolution of isoenzyme peaks than did KC1 or NaC!. The rates of inactivation by heat that we observed correspond with the results of Posen eta!. (11). They demonstrated that serum from patients with bone diseases was more heat sensitive than serum from patients with liver diseases. The low inactivation rates with i.1-phenylalanine demonstrated that the peaks of bone and liver activity contained no small-intestinal isoenzyme activity. the other isoenzyme were inhibited by 15% or less (7) .
For identification of separated isoenzymes by our method, it was necessary to obtain identical elution times for isoen- Heat, 56'C,10 mm zymes from serum and from tissue homogenates. This was done by avoiding extraction of the tissue with nonionic detergents or butanol, which form complexes with alkaline phosphatase and derange the chromatographic and electrophoretic properties of isoenzymes (13, 16) .
The advantage of our method is the exact and complete separation of A? isoenzymes. The origin of the first peak (small-intestine or the first bone isoenzyme) in sera could be clarifiedby inhibition with 5 minol/L L-phenylalanine in the respective fraction, the isoenzyme of small intestine being more rapidly inactivated.
Automation
of our method by use of a fully automated system of HPLC would allow its routine application and may improve the diagnostic value of A? determination.
